Melek Aslan Kayıran
Istanbul, Turkey (Türkiye)
NCT Number: NCT04207242
Psoriasis Vulgaris is a chronic, recurrent, inflammatory and hyperproliferative skin disease. Joint involvement is common along with skin involvement. However, metabolic diseases, such as cardiovascular diseases can be accompanied by many systemic diseases, chronic and repetitive due to the quality of life and psychological status of patients can affect. For this reason, patients carry out various research on their diseases on social media and follow programs on these issues in other media such as television and radio. However, there is no study on how much patients are interested in these publications, how much they trust them, and how they reach and organize information via social media. The aim of the study will be to clarify how and how patients with Psoriasis Vulgaris use social media to obtain information about the diagnosis and treatment of their disease, the interaction of patient groups with each other, and how often social media is used, especially in which group of patients.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Istanbul, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: July 2020
Istanbul Medeniyet University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04306315
Psoriasis Vulgaris
Brussels, Belgium
View Trial DetailsNCT03372811
Psoriasis, Psoriasis Vulgaris
New York, United States
View Trial DetailsNCT04340076
Psoriasis, Psoriasis Vulgaris
Brussels, Belgium
View Trial DetailsNCT05442190
Plaque Psoriasis, Psoriasis
San Diego, California, United States
View Trial Details